Tag: Agitation management

Approximately 50-70% of patients with delirium experience aggressive agitation that can pose a safety risk to themselves and others. This guide outlines the proper medical approach for managing and determining how to sedate an aggressive patient when non-pharmacological interventions prove insufficient.

Developed decades ago, the B52 medical cocktail combines three potent medications to manage acute agitation in emergency settings. While historically a common treatment, recent clinical studies have raised significant concerns, prompting many medical institutions to move toward safer, evidence-based alternatives. The discussion of what are the benefits of the B52 is now accompanied by a critical re-evaluation of its safety profile.